Skip to content
Home/Companies/Biotech/Tribune Therapeutics
TT

Tribune Therapeutics

Biotech·Sweden·Active·1yr hold

Tribune Therapeutics is a biotech company, headquartered in Sweden.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Tribune Therapeutics?

Tribune Therapeutics is currently owned by LifeArc through LifeArc Ventures (1992 vintage), since 2025.

Hand-verified · updated 2026-07-07

LifeArc
Investor
LifeArc
LifeArc Ventures · 1992 · Life Sciences VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from LifeArc Ventures

Other portfolio companies in the same fund.

Exciva
Active
BiotechGermany· 2026
GlycoEra
Active
BiotechSwitzerland· 2025
Hillstar Bio
Active
BiotechUnited States· 2025
Fluid Biomed
Active
MedTechCanada· 2024
Affect Therapeutics
Active
HealthTechUnited States· 2023
Cytospire Therapeutics
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings